Animal studies have also revealed a reduction in the levels of PGC-1α, Nrf1, Nrf2, and TFAM in the brain tissue of triple transgenic Alzheimer’s disease mouse models (3 × Tg-AD) (Singulani et al., 2020). This evidence concerns the gene PPARGC1A and Alzheimer disease.